Both in Biotechnology
Novavax vs Vericel
Over the past year NVAX returned +27.4% and VCEL returned +9.7%; their daily moves had a correlation of 0.18.
NVAX +27.4% VCEL +9.7%Growth of $1, one year, split-adjusted
| Metric | NVAX | VCEL |
|---|---|---|
| Price | $10.08 | $40.26 |
| Market cap | $1.66B | $2.06B |
| Today | −3.72% | −6.18% |
| 1 month | −4.9% | +2.1% |
| 6 months | +25.4% | +13.2% |
| Year to date | +50.0% | +11.8% |
| 1 year | +20.3% | +15.4% |
| Revenue growth (YoY) | −76.3% | +22.5% |
| Gross margin | 74.9% | 72.8% |
| Net margin | −94.2% | 2.8% |
| P/E (TTM) | — | 85.1× |
| Price / sales | 4.0× | 6.7× |
| Net cash | $422.0M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.8% | 33.0% |
| Short % of float | 30.3% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).